The C37A protocol has been validated or used in investigations to produce commutable samples for several other analytes [8], but it would hardly be applicable to the preparation of samples for cTnI measurement because detectable cTnI is primarily seen in MI patients. This evidence concerns the gene TNNI3 and myocardial infarction.